New Key Statistics Module, Z-Score and F-Score
OTCPK:CSMYF Key Ratios
| Market Cap $ M | 3,245.86 |
| Enterprise Value $ M | 3,285.84 |
| P/E(ttm) | 15.42 |
| PE Ratio without NRI | 15.29 |
| Forward PE Ratio | 14.75 |
| Price/Book | 1.74 |
| Price/Sales | 0.45 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | 0.20 |
| Revenue (TTM) $ M | 7,143.00 |
| EPS (TTM) $ | 2.63 |
| Beneish M-Score | -2.15 |
| 10-y EBITDA Growth Rate % | 7.60 |
| 5-y EBITDA Growth Rate % | 7.00 |
| y-y EBITDA Growth Rate % | 7.00 |
| EV-to-EBIT | 11.42 |
| EV-to-EBITDA | 6.31 |
| PEG | 2.18 |
| Shares Outstanding M | 79.26 |
| Net Margin (%) | 2.91 |
| Operating Margin % | 3.85 |
| Pre-tax Margin (%) | 4.02 |
| Quick Ratio | 0.36 |
| Current Ratio | 0.77 |
| ROA % (ttm) | 5.86 |
| ROE % (ttm) | 11.89 |
| ROIC % (ttm) | 7.42 |
| Dividend Yield % | 1.41 |
| Altman Z-Score | 3.81 |
CSMYF Number of Guru Trades
CSMYF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CSMYF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CSMYF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
COSMOS Pharmaceutical Corp Insider Transactions
No Available Data
News about OTCPK:CSMYF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers